Mark Spoto Biography and Net Worth

Director of 908 Devices

At Razor’s Edge, Mark Spoto is responsible for the fund’s day-to-day business operations. His primary responsibilities include the identification and evaluation of investment opportunities, market and industry analyses, deal structuring, fundraising, and LP relations, as well as support of and advice to Razor’s Edge portfolio companies. Prior to joining Razor’s Edge, Mark was a partner in the Reston, Virginia office of Cooley LLP, a national law firm. He worked with many emerging and high growth technology companies and investment funds, and his practice focused on mergers and acquisitions, venture capital, private equity and public securities offerings, and general corporate representation. His operating company clients were engaged in high-growth industry sectors including software, government contracts, aerospace/defense, telecommunications, and media.

From 2008-2011, Chambers USA named Mark to its list of America’s Leading Lawyers for Business, and in 2009, he was selected by The Legal 500 as a leading lawyer in the fields of venture capital and emerging companies. Prior to practicing law, Mark was an aerospace engineer, working on the Air Force Titan IV rocket program for McDonnell Douglas Space Systems Company. He serves on the boards of directors of several private companies, including BlackVe, HawkEye 360, and X-Bow Systems. He holds a bachelor’s degree in aerospace engineering from Boston University and a J.D. from Georgetown University Law Center.

What is Mark Spoto's net worth?: The estimated net worth of Mark Spoto is at least $418.76 thousand as of May 14th, 2025. Spoto owns 62,971 shares of 908 Devices stock worth more than $418,757 as of December 4th. This net worth estimate does not reflect any other investments that Spoto may own. Learn More about Mark Spoto's net worth.
How do I contact Mark Spoto?: The corporate mailing address for Spoto and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected]. Learn More on Mark Spoto's contact information.
Has Mark Spoto been buying or selling shares of 908 Devices?: Mark Spoto has not been actively trading shares of 908 Devices within the last three months. Most recently, on Wednesday, May 14th, Mark Spoto bought 10,000 shares of 908 Devices stock. The stock was acquired at an average cost of $4.29 per share, with a total value of $42,900.00. Following the completion of the transaction, the director now directly owns 62,971 shares of the company's stock, valued at $270,145.59. Learn More on Mark Spoto's trading history.
Who are 908 Devices' active insiders?: 908 Devices' insider roster includes Nicolas Barthelemy (VP), Trent Basarsky (VP), Christopher Brown (CTO), Joseph Griffith, IV (CFO), John Kenneweg (VP), Kevin Knopp (CEO), Mark Spoto (Director), and Michael Turner (Insider). Learn More on 908 Devices' active insiders.
Are insiders buying or selling shares of 908 Devices?: In the last year, 908 Devices insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $42,900.00. In the last year, insiders at the sold shares 9 times. They sold a total of 61,451 shares worth more than $360,970.92. The most recent insider tranaction occured on October, 3rd when CFO Joseph H Iv Griffith sold 4,292 shares worth more than $38,842.60. Insiders at 908 Devices own 23.7% of the company. Learn More about insider trades at 908 Devices.
Information on this page was last updated on 10/3/2025.

Mark Spoto Insider Trading History at 908 Devices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2025	Buy	10,000	$4.29	$42,900.00	62,971
11/22/2022	Buy	2,585	$9.65	$24,945.25	40,423

Mark Spoto Buying and Selling Activity at 908 Devices

908 Devices Company Overview

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $6.65

$6.01

$6.65

50 Day Range

MA: $7.46

$5.35

$9.15

2 Week Range

Now: $6.65

$1.81

$9.34

Volume

340,398 shs

Average Volume

411,201 shs

Market Capitalization

$240.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47